Abstract
Traditionally, camel milk has been prescribed for diabetes, possibly due to content of insulin-like molecules. In this clinical trial, 40 patients with type 2 diabetes mellitus (T2DM) who used long-acting insulin analogues were randomly assigned into two groups and received 500 mL of raw camel or cow milk daily for three months. Fasting blood sugar decreased significantly in the camel milk group compared with that in the cow milk group. A significant reduction (P ˂ 0.05) in HbA1c was observed in both groups (camel milk, −3.0 ± 2.0%; cow milk, −1.9 ± 2.6%). The dose of insulin required was decreased in patients that received camel milk (13.7%). Total cholesterol significantly decreased in the cow milk group in comparison with the camel milk group. Insulin resistance and other serum lipids showed no statistical differences between the two groups. Camel milk could be effective for glycaemic control in T2DM patients using long-acting insulin.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.